Literature DB >> 19779649

Cortactin is involved in transforming growth factor-beta1-induced epithelial-mesenchymal transition in AML-12 cells.

Kehua Zhang1, Dongmei Wang, Jianguo Song.   

Abstract

Cortactin is an F-actin binding protein, regulating cell movement and adhesive junction assembly. However, the function of cortactin in epithelial-mesenchymal transition (EMT) remains elusive. Here we found that during transforming growth factor-beta1 (TGF-beta1)- induced EMT in AML-12 murine hepatocytes, cortactin underwent tyrosine dephosphorylation. Inhibition of the dephosphorylation of cortactin by sodium vanadate blocked TGF-beta1-induced EMT. Knockdown of cortactin by RNAi led to decrease of intercellular junction proteins E-cadherin and Zonula occludens-1 and induced expression of mesenchymal protein fibronectin. Additionally, knockdown of cortactin further promoted TGF-beta1-induced EMT in AML-12 cells, as determined by EMT markers and cell morphological changes. Moreover, migration assay showed that cortactin knockdown promoted the migration of AML-12 cells, and also enhanced TGF-beta1-induced migration. Our study showed the involvement of cortactin in the TGFbeta1- induced EMT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779649     DOI: 10.1093/abbs/gmp070

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  9 in total

1.  Protein interactions of cortactin in relation to invadopodia formation in metastatic renal clear cell carcinoma.

Authors:  Hong-Liang Shen; Qing-Jun Liu; Pei-Qian Yang; Ye Tian
Journal:  Tumour Biol       Date:  2014-12-21

Review 2.  Cortactin: a multifunctional regulator of cellular invasiveness.

Authors:  Kellye C Kirkbride; Bong Hwan Sung; Seema Sinha; Alissa M Weaver
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Expression and clinical significance of cortactin protein in ovarian neoplasms.

Authors:  A Li; L Zhang; X Zhang; W Jin; Y Ren
Journal:  Clin Transl Oncol       Date:  2015-08-05       Impact factor: 3.405

4.  Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway.

Authors:  Huo Wu; Xiaoqian Jing; Xi Cheng; Yonggang He; Lei Hu; Haoxuan Wu; Feng Ye; Ren Zhao
Journal:  Oncotarget       Date:  2016-11-08

5.  MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.

Authors:  Min Ma; Juanxia Zhao; Qunfeng Wu; Ke Xiao; Shuang Li; Haizhen Zhu; Chen Liu; Hailong Xie; Chaohui Zuo
Journal:  Cancer Med       Date:  2018-05-07       Impact factor: 4.452

6.  Mediator MED23 regulates inflammatory responses and liver fibrosis.

Authors:  Zhichao Wang; Dan Cao; Chonghui Li; Lihua Min; Gang Wang
Journal:  PLoS Biol       Date:  2019-12-05       Impact factor: 8.029

7.  Hepatocyte-Specific Smad4 Deficiency Alleviates Liver Fibrosis via the p38/p65 Pathway.

Authors:  Miaomiao Wei; Xinlong Yan; Xin Xin; Haiqiang Chen; Lingling Hou; Jinhua Zhang
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

8.  Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity.

Authors:  Yajing Chu; Leonardo Gómez Rosso; Ping Huang; Zhichao Wang; Yichi Xu; Xiao Yao; Menghan Bao; Jun Yan; Haiyun Song; Gang Wang
Journal:  Cell Res       Date:  2014-09-16       Impact factor: 25.617

Review 9.  Cortactin in Epithelial-Mesenchymal Transition.

Authors:  Rong Ji; Xiao-Juan Zhu; Zhi-Rong Wang; Li-Qiang Huang
Journal:  Front Cell Dev Biol       Date:  2020-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.